Last updated on 25 Jun 2024
Owner Info
Idera Pharmaceuticals, Inc.
505 Eagleview Blvd.
Exton PA 19341, UNITED STATES OF AMERICA
Serial Number
2160257 filed on 5 Jan 2021
Correspondent
Rebecca E. McDougall, Morgan, Lewis & Bockius LLP
1111 Pennsylvania Avenue, NW,
Washington DC 20004-2541,
UNITED STATES OF AMERICA
2160257
5 Jan 2021
NA
WORD
8 Jul 2020
US
Status Date | Action Taken |
---|---|
25th Jun 2024 | Status change to Voided |
27th May 2021 | International Registration in Australia Protected correspondence sent |
26th May 2021 | IP Right Registration Published |
26th May 2021 | Status change to Registered/Protected |
20th Mar 2021 | Application Accepted correspondence sent |
19th Mar 2021 | IP Right has been Examined |
19th Mar 2021 | IP Right Acceptance Published |
19th Mar 2021 | Status change to Accepted |
4th Mar 2021 | Awaiting examination |
4th Mar 2021 | Examination expedited |